| Purpose | Announcement Date | Split Date | Record Date | Face Value (before split) | Face Value (after split) |
|---|---|---|---|---|---|
| Split | 22 Aug 2025 | 16 Oct 2025 | 16 Oct 2025 | 10 | 1 |
| Board of Directors of the Company was held on Friday, 22nd August, 2025. In the meeting the Board has decided the following matters: The Board has considered and approved Sub-division/ split of the existing Equity Shares of the Company, such that each Equity Share having face value of Rs. 10/- (Rupees Ten only) each fully paid-up, be sub-divided/split into such number of Equity Shares having face value of Rs. 1 each fully paid-up, subject to the approval of Equity Shareholders of the Company through Postal Ballot. The Record Date for sub-division/split of existing Equity Shares shall be decided after taking aforesaid approval of the Equity Shareholders of the Company. Trading Members of the Exchange are hereby informed that WELCURE DRUGS & PHARMACEUTICALS LTD, has fixed Record Date for the purpose of Sub-Division and Bonus Issue of Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE WELCURE DRUGS & PHARMACEUTICALS LTD (524661) RECORD DATE 16/10/2025 PURPOSE Subdivision of existing Equity Shares from One Equity Share of Rs.10/- each into Ten Equity Shares of Re.1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 16/10/2025 DR-737/2025-2026 Note: - i. ISIN No. INE331C01017 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 16/10/2025. ii. The new ISIN Number for Re. 1/- paid up will be informed to the market by a separate notice. iii. As informed by the company 1,12,35,820 equity shares would be allotted as on 17th October,2025 (Refer attached Companys Letter dated October 09, 2025) (As Per BSE Notice Dated on 13.10.2025) In Continuation to the Exchange Notice No. 20251013-18 dated October 13, 2025, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: - Company Name & Scrip Code Welcure Drugs & Pharmaceuticals Ltd (524661) New ISIN No. INE331C01025 Remarks Sub-Division of Equity Shares from Rs.10/- to Re. 1/- The new ISIN number given above for Equity Shares of Re.1/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 16-10-2025 (DR- 737/2025-2026) (As Per BSE Notice Dated on 14.10.2025) In continuation to the Exchange Notice No. 20251013-18 dated October 13,2025 , inter alia, nforming therein the Record Date fixed on 16.10.2025 for the purpose of Bonus Issue (Ratio: 01:10) by WELCURE DRUGS & PHARMACEUTICALS LTD. (scrip code: 524661). In the Point no. iii of the said Notice, the company had informed the pre Stock Split Bonus shares to be allotted would be 1,12,35,820 Equity Shares of Rs.10/- each. Trading Members are requested to take note that as now informed by the Company Post Stock Split from Rs.10 to Re1/- per share, the Company will Issue and allot 11,23,58,200 Bonus Equity Shares of Re.1/ each on 17th October,2025 (Refer attached Companys Revised Annexure I Final dated October 17, 2025) Trading Members of the Exchange are requested to take note of the same. (As Per BSE Notice Dated on 17.10.2025) | |||||
In addition, a 10:1 stock split has been cleared, dividing one equity share of ₹10 each into 10 shares of ₹1 each.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
